Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP817087.RABDKMWX5uZVFN2hrKtSnr_nFmnnYfJmQuwHshCKKduGw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP817087.RABDKMWX5uZVFN2hrKtSnr_nFmnnYfJmQuwHshCKKduGw130_assertion type Assertion NP817087.RABDKMWX5uZVFN2hrKtSnr_nFmnnYfJmQuwHshCKKduGw130_head.
- NP817087.RABDKMWX5uZVFN2hrKtSnr_nFmnnYfJmQuwHshCKKduGw130_assertion description "[Recent studies suggest that targeting PTEN/PI3K/Akt and mTOR signaling pathway could be an effective strategy for the treatment of hormone refractory CaP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP817087.RABDKMWX5uZVFN2hrKtSnr_nFmnnYfJmQuwHshCKKduGw130_provenance.
- NP817087.RABDKMWX5uZVFN2hrKtSnr_nFmnnYfJmQuwHshCKKduGw130_assertion evidence source_evidence_literature NP817087.RABDKMWX5uZVFN2hrKtSnr_nFmnnYfJmQuwHshCKKduGw130_provenance.
- NP817087.RABDKMWX5uZVFN2hrKtSnr_nFmnnYfJmQuwHshCKKduGw130_assertion SIO_000772 20530556 NP817087.RABDKMWX5uZVFN2hrKtSnr_nFmnnYfJmQuwHshCKKduGw130_provenance.
- NP817087.RABDKMWX5uZVFN2hrKtSnr_nFmnnYfJmQuwHshCKKduGw130_assertion wasDerivedFrom befree-2016 NP817087.RABDKMWX5uZVFN2hrKtSnr_nFmnnYfJmQuwHshCKKduGw130_provenance.
- NP817087.RABDKMWX5uZVFN2hrKtSnr_nFmnnYfJmQuwHshCKKduGw130_assertion wasGeneratedBy ECO_0000203 NP817087.RABDKMWX5uZVFN2hrKtSnr_nFmnnYfJmQuwHshCKKduGw130_provenance.